MA38100A1 - Forme solide d'un dérivé de dihydro-pyrido-oxazine - Google Patents
Forme solide d'un dérivé de dihydro-pyrido-oxazineInfo
- Publication number
- MA38100A1 MA38100A1 MA38100A MA38100A MA38100A1 MA 38100 A1 MA38100 A1 MA 38100A1 MA 38100 A MA38100 A MA 38100A MA 38100 A MA38100 A MA 38100A MA 38100 A1 MA38100 A1 MA 38100A1
- Authority
- MA
- Morocco
- Prior art keywords
- dihydro
- pyridooxazine
- derivative
- solid form
- forms
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La présente invention concerne une forme cristalline anhydre de (1,1-dioxo-hexahydro-1lambda*6*- thiopyran-4-yl)-{(s)-3-[1-(6-méthoxy-5-méthyl-pyridin-3-yl)-2,3-dihydro-1h-pyrido[3,4-b][1,4]oxazin-7-yloxy]-pyrrolidin-1-yl}-méthanone; des compositions et des combinaisons pharmaceutiques incluant ces formes ainsi que des procédés d'utilisation de ces formes, incluant leurs compositions et combinaisons pharmaceutiques pour le traitement de maladies.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GC201222895 | 2012-11-26 | ||
PCT/IB2013/060412 WO2014102630A1 (fr) | 2012-11-26 | 2013-11-26 | Forme solide d'un dérivé de dihydro-pyrido-oxazine |
Publications (1)
Publication Number | Publication Date |
---|---|
MA38100A1 true MA38100A1 (fr) | 2017-12-29 |
Family
ID=54198861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA38100A MA38100A1 (fr) | 2012-11-26 | 2013-11-26 | Forme solide d'un dérivé de dihydro-pyrido-oxazine |
Country Status (8)
Country | Link |
---|---|
JP (1) | JP6310474B2 (fr) |
EA (1) | EA028031B1 (fr) |
ES (1) | ES2643902T3 (fr) |
HR (1) | HRP20171573T1 (fr) |
HU (1) | HUE036665T2 (fr) |
LT (1) | LT2928896T (fr) |
MA (1) | MA38100A1 (fr) |
SI (1) | SI2928896T1 (fr) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010027002A1 (fr) * | 2008-09-05 | 2010-03-11 | 塩野義製薬株式会社 | Derive de morpholine à cycles condensés ayant une activite inhibitrice de pi3k |
PL2794600T3 (pl) * | 2011-12-22 | 2018-06-29 | Novartis Ag | Pochodne 2,3-dihydro-benzo[1,4]oksazyny i powiązane związki jako inhibitory kinazy fosfoinozytydu-3 (PI3K) do leczenia np. reumatoidalnego zapalenia stawów |
-
2013
- 2013-11-26 EA EA201591023A patent/EA028031B1/ru not_active IP Right Cessation
- 2013-11-26 HU HUE13824177A patent/HUE036665T2/hu unknown
- 2013-11-26 SI SI201330781T patent/SI2928896T1/sl unknown
- 2013-11-26 MA MA38100A patent/MA38100A1/fr unknown
- 2013-11-26 JP JP2015543559A patent/JP6310474B2/ja active Active
- 2013-11-26 LT LTEP13824177.3T patent/LT2928896T/lt unknown
- 2013-11-26 ES ES13824177.3T patent/ES2643902T3/es active Active
-
2017
- 2017-10-17 HR HRP20171573TT patent/HRP20171573T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
SI2928896T1 (sl) | 2017-10-30 |
JP6310474B2 (ja) | 2018-04-11 |
EA028031B1 (ru) | 2017-09-29 |
ES2643902T3 (es) | 2017-11-27 |
HUE036665T2 (hu) | 2018-07-30 |
LT2928896T (lt) | 2017-09-25 |
HRP20171573T1 (hr) | 2017-11-17 |
JP2016502531A (ja) | 2016-01-28 |
EA201591023A1 (ru) | 2015-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA31470B1 (fr) | Dérivés de pipéridine utiles comme antagonistes vis-à-vis des récepteurs de l'orexine | |
MA32351B1 (fr) | Derives d'aminodihydrothiazine a titre d'inhibiteurs de bace pour le traitement de la maladie d'alzheimer | |
MA37379A1 (fr) | Formes polymorphes de l'acide -2-(1-(9h-purine-6-ylamino)propyl)-5-fluoro-3-phénylquinazolin-4(3h)-one | |
MA39211B1 (fr) | Composés tricycliques comme agents anti-cancers | |
MA33350B1 (fr) | Anticorps humanises specifiques de la forme protofibrillaire du peptide beta-amyloide | |
MA34019B1 (fr) | Aryltriazolone liée à un bis-aryle et son utilisation | |
MA32729B1 (fr) | Derives d'acide 1-amino-2-cyclobutylethylboronique | |
MY150518A (en) | Substituted gamma lactams as therapeutic agents | |
EA201000642A1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
EA200901157A1 (ru) | Конденсированные кольцевые гетероциклические модуляторы киназы | |
MA33123B1 (fr) | 2-acetamido-5-aryl-1,2,4-triazolones substitues et leur utilisation | |
EA201070328A1 (ru) | Соединения триазолопиридина и их применение в качестве ингибиторов ask | |
MA32257B1 (fr) | Hydroxymethyl pyrrolidines comme agonistes des recepteurs beta-3- adrenergiques. | |
MA34248B1 (fr) | 5-fluoro-1h-pyrazolopyridines substituées et leur utilisation | |
MA32471B1 (fr) | Composés de borates esters et compositions pharmaceutiques contenant des composés | |
MA38071B1 (fr) | Formes cristallines d'un inhibiteur de facteur xia | |
DE502006006854D1 (de) | Substituierte benzo (d) isoaxol-3-yl-amin-verbindungen als analgetika | |
MA33132B1 (fr) | Derives pyrazole utilises comme antagonistes du recepteur ccr4 | |
TW200631583A (en) | Substituted pteridines for the treatment of inflammatory diseases | |
MA38714A1 (fr) | Procédés de production et formes cristallines d'un inhibiteur mdm2 | |
IL193479A0 (en) | Modulators of muscarinic receptors | |
PH12013501321B1 (en) | Phenoxymethyl heterocyclic compounds | |
MA33679B1 (fr) | Derives de 2-oxo-1-pyrrolidinyle imidazothiadiazole | |
MY183111A (en) | 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators | |
EA201101118A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина |